Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment

Silvia Ghione (1) , Nesrine Mabrouk (1) , Catherine Paul (1) , Ali Bettaieb (1) , Stéphanie Plenchette (1)

1 LIIC - Laboratoire d'Immunologie et d'Immunothérapie des cancers [Dijon]

Domaines: Sciences du Vivant [q-bio]

Silvia Ghione, Nesrine Mabrouk, Catherine Paul, Ali Bettaieb, Stéphanie Plenchette. Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment. Biochemical Pharmacology, 2020, 176, pp.113855 -. ⟨10.1016/j.bcp.2020.113855⟩. ⟨hal-03490290⟩